Effect of deferoxamine and hyperbaric oxygen on free, autogenous, full-thickness skin grafts in dogs

Giselle Hosgood From the Departments of Veterinary Clinical Sciences (Hosgood, Lewis) and Veterinary Physiology, Pharmacology, and Toxicology (Strain), and the Louisiana Veterinary Diagnostic Laboratory, Department of Pathology (Hodgin, Lopez), School of Veterinary Medicine, Louisiana State University, Baton Rouge, LA 70803.

Search for other papers by Giselle Hosgood in
Current site
Google Scholar
PubMed
Close
 BVSc, MS
,
E. Clay Hodgin From the Departments of Veterinary Clinical Sciences (Hosgood, Lewis) and Veterinary Physiology, Pharmacology, and Toxicology (Strain), and the Louisiana Veterinary Diagnostic Laboratory, Department of Pathology (Hodgin, Lopez), School of Veterinary Medicine, Louisiana State University, Baton Rouge, LA 70803.

Search for other papers by E. Clay Hodgin in
Current site
Google Scholar
PubMed
Close
 DVM, PhD
,
George M. Strain From the Departments of Veterinary Clinical Sciences (Hosgood, Lewis) and Veterinary Physiology, Pharmacology, and Toxicology (Strain), and the Louisiana Veterinary Diagnostic Laboratory, Department of Pathology (Hodgin, Lopez), School of Veterinary Medicine, Louisiana State University, Baton Rouge, LA 70803.

Search for other papers by George M. Strain in
Current site
Google Scholar
PubMed
Close
 PhD
,
Mae K. Lopez From the Departments of Veterinary Clinical Sciences (Hosgood, Lewis) and Veterinary Physiology, Pharmacology, and Toxicology (Strain), and the Louisiana Veterinary Diagnostic Laboratory, Department of Pathology (Hodgin, Lopez), School of Veterinary Medicine, Louisiana State University, Baton Rouge, LA 70803.

Search for other papers by Mae K. Lopez in
Current site
Google Scholar
PubMed
Close
 BS
, and
Daniel D. Lewis From the Departments of Veterinary Clinical Sciences (Hosgood, Lewis) and Veterinary Physiology, Pharmacology, and Toxicology (Strain), and the Louisiana Veterinary Diagnostic Laboratory, Department of Pathology (Hodgin, Lopez), School of Veterinary Medicine, Louisiana State University, Baton Rouge, LA 70803.

Search for other papers by Daniel D. Lewis in
Current site
Google Scholar
PubMed
Close
 DVM

Click on author name to view affiliation information

SUMMARY

Free, autogenous, full-thickness skin grafts were applied to 10 dogs; 5 dogs were given an iron chelator, deferoxamine-10% hydroxyethyl pentafraction starch (def-hes; 50 mg/kg of body weight, iv), and 5 dogs were given an equal volume of 10% hydroxyethyl pentafraction starch (hes) in 0.9% saline solution (5 ml/kg, iv). All dogs (def-hes/hbo- and hes/hbo-treated) were exposed to 60 minutes of hyperbaric oxygen (hbo) at 2 atmospheres absolute pressure twice daily for 10 days, beginning the day of surgery. The percentage of viable graft on day 10 was lower in hes/hbo-treated dogs (mean ± sd, 13.3 ± 21.3%; median, 3.0%) than in def-hes/hbo-treated dogs (64.7 ± 39.2%; 88.3%; P = 0.095, Mann-Whitney two-tailed test). There was a positive correlation between percentage of viable graft (on day 10) and percentage of haired skin on the graft site (on day 28) for all dogs (r = 0.91) and for hes/hbo-treated dogs (r = 0.97). The def-hes/hbo-treated dogs had less consistent correlation (r = 0.67). Perivascular aggregates of foamy cells were observed in the superficial and reticular portions of the dermis and in the subcutaneous tissue on both surfaces of the panniculus muscle in the graft sites of def-hes/hbo-treated dogs. These cells were also observed in the dermis, but not subcutaneous tissue of the control skin sections, and in some viscera of def-hes/hbo-treated dogs. Deferoxamine appears to attenuate the detrimental effect of hbo and hes on survival of free skin grafts. However, clinical use of hbo is not recommended as adjunct treatment for free skin grafts in dogs in the first 10 days after grafting. Administration of def-hes is not recommended because it has failed to improve the survival of free skin grafts, and the consequence of the cellular response seen in this study is undetermined.

SUMMARY

Free, autogenous, full-thickness skin grafts were applied to 10 dogs; 5 dogs were given an iron chelator, deferoxamine-10% hydroxyethyl pentafraction starch (def-hes; 50 mg/kg of body weight, iv), and 5 dogs were given an equal volume of 10% hydroxyethyl pentafraction starch (hes) in 0.9% saline solution (5 ml/kg, iv). All dogs (def-hes/hbo- and hes/hbo-treated) were exposed to 60 minutes of hyperbaric oxygen (hbo) at 2 atmospheres absolute pressure twice daily for 10 days, beginning the day of surgery. The percentage of viable graft on day 10 was lower in hes/hbo-treated dogs (mean ± sd, 13.3 ± 21.3%; median, 3.0%) than in def-hes/hbo-treated dogs (64.7 ± 39.2%; 88.3%; P = 0.095, Mann-Whitney two-tailed test). There was a positive correlation between percentage of viable graft (on day 10) and percentage of haired skin on the graft site (on day 28) for all dogs (r = 0.91) and for hes/hbo-treated dogs (r = 0.97). The def-hes/hbo-treated dogs had less consistent correlation (r = 0.67). Perivascular aggregates of foamy cells were observed in the superficial and reticular portions of the dermis and in the subcutaneous tissue on both surfaces of the panniculus muscle in the graft sites of def-hes/hbo-treated dogs. These cells were also observed in the dermis, but not subcutaneous tissue of the control skin sections, and in some viscera of def-hes/hbo-treated dogs. Deferoxamine appears to attenuate the detrimental effect of hbo and hes on survival of free skin grafts. However, clinical use of hbo is not recommended as adjunct treatment for free skin grafts in dogs in the first 10 days after grafting. Administration of def-hes is not recommended because it has failed to improve the survival of free skin grafts, and the consequence of the cellular response seen in this study is undetermined.

All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 30 30 7
PDF Downloads 20 20 1
Advertisement